Experiencia en el Hospital Universitario Basurto con secukinumab para el tratamiento de la psoriasis moderada-grave [PDF]
, 2018 [ES] Hemos realizado un estudio descriptivo retrospectivo para valorar la respuesta y la seguridad del tratamiento con secukinumab, un biológico anti IL-17, durante 52 semanas en pacientes con psoriasis moderada-grave.
Orbea Sopeña, Ana
core
Dermofarmazia. Osasuna kanpoaldetik zaintzea [PDF]
, 2016 196 p.Aurkibidea: 1. Sarrera. 2. Larruazalaren eta larruazal-eranskinen histologia eta fisiología. 3. Aurpegiaren garbiketa. 4. Aurpegiaren hidratazioa. 5. Aknea. 6. Larruazala zahartzea. 7. Larruazalaren pigmentazioa. 8. Eguzki-babesa.
Esquisabel Alegría, Amaya +1 more
core +1 more source
Perfil clínico dos pacientes com psoríase. [PDF]
, 1999 Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Clínica Médica, Curso de Medicina, Florianópolis ...
Conti, Maurício Amboni
core
Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel. [PDF]
Hematol Transfus Cell Ther, 2022 Velloso EDRP +17 more
europepmc +1 more source
Operational definition of complementary, alternative, and integrative medicine derived from a systematic search. [PDF]
BMC Complement Med Ther, 2022 Ng JY +6 more
europepmc +1 more source
[Phytophotodermatitis. Also the skin in the city]. [PDF]
Aten Primaria, 2020 Fabà Gabarroca MC, Delás J.
europepmc +1 more source
NORMALIZING EFFECT OF GAMMA-LINOLENIC ACID ON ETRETINATE-INDUCED HYPERTRIGLY- CERIDEMIA IN PSORIATIC PATIENTS: PRELIMINARY RESULTS [PDF]
, 2020 _________________ Synopsis Retinoids are a group of. synthesis compounds having vitamin A as their precursor. Among retino i d s, etretin ate i s commonly used, al o n e or in combi n ati o n with PUVA (8-methoxypsoralen+UYA), for diffuse and resistant ...
C Zaccone +4 more
core
[PAPPS Expert Groups. Cancer prevention recommendations: Update 2022]. [PDF]
Aten Primaria, 2022 Marzo-Castillejo M +4 more
europepmc +1 more source
Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas [PDF]
Background and objectives: Bexarotene has been approved to treat advanced stage cutaneous T -cell lymphomas (CTCL) since 1999. However, very few data have been published on its long-term safety and efficacy profile.
Acebo-mariñas, E. +21 more
core +2 more sources